Workflow
Zhi Tong Cai Jing
icon
Search documents
卧安机器人(06600)获纳入恒生综合指数成份股
Zhi Tong Cai Jing· 2026-02-13 14:49
(原标题:卧安机器人(06600)获纳入恒生综合指数成份股) 智通财经APP讯,卧安机器人(06600)发布公告,公司已获恒生指数有限公司选定并将纳入恒生综合指数成份股,自2026年3月9日起生效。获纳入 恒生综合指数成份股后,公司股票预计将符合沪港通及深港通交易的纳入标准。沪港通及深港通是香港与中国内地的资本市场投资者之间的股票 交易与投资的渠道。 董事会认为,纳入恒生综合指数成份股反映国际资本市场对公司行业地位、业务表现及价值的高度认可,将有助于扩大公司的股东基础及吸引更 多长期机构投资者,为公司长期发展奠定坚实基础,并为股东创造可持续价值,从而提高公司于资本市场的投资价值及声誉。 董事会谨此向所有股东、投资者及合作伙伴长期以来的信任及支持致以衷心谢意。公司将继续聚焦技术创新及业务开发,深化在具身智能领域的 布局。 ...
再鼎医药(ZLAB.US)涨逾7% 注射用ZL-1310拟纳入突破性疗法
Zhi Tong Cai Jing· 2026-02-13 14:48
Core Viewpoint - Zai Ding Pharmaceutical (ZLAB.US) saw a more than 7% increase in stock price, reaching $20.11, following the announcement that its injectable ZL-1310 is proposed to be included as a breakthrough therapy for extensive-stage small cell lung cancer (ES-SCLC) patients during or after platinum-based treatment [1] Group 1 - ZL-1310 has shown outstanding efficacy data in early clinical studies, particularly in patients receiving second-line treatment and those with brain metastases, indicating its potential to become a breakthrough therapy in the SCLC treatment field [1]
瓦普思瑞元宇宙公布中期业绩 公司拥有人应占亏损962万港元 同比盈转亏
Zhi Tong Cai Jing· 2026-02-13 14:44
公告称,收入增长主要得益于新业务逐步启动,带动整体收入提升。由盈转亏,主要系受市场整体风险 变化影响,集团对其他应收款项及预付款项增加计提信贷亏损拨备。 瓦普思瑞元宇宙(08093)公布截至2025年12月31日止6个月中期业绩,收入4624.3万港元,同比增长 131.49%;公司拥有人应占亏损962万港元,同比盈转亏;每股亏损21.96港仙。 ...
东亚银行获纳入恒生综合指数 有望成为港股通标的
Zhi Tong Cai Jing· 2026-02-13 14:44
Group 1 - The Hang Seng Index Company announced the inclusion of Bank of East Asia (00023) in the Hang Seng Composite Index, effective March 9, 2026, following a quarterly review [1] - Bank of East Asia reported a decrease in interest income to HKD 32.968 billion, down 17.18% year-on-year, and a drop in profit attributable to shareholders to HKD 3.501 billion, down 24.02% year-on-year, with basic earnings per share at HKD 1.22 [1] - The core business of the group remains stable, with operating profit before provisions holding steady at HKD 11.2 billion, and non-interest income growing by 28%, indicating successful strategies in business diversification and sustainable growth [1] Group 2 - The company continues to prudently make provisions for its exposure to commercial real estate, with 77% of this year's provisions related to commercial properties in Hong Kong and mainland China [2] - The valuation of the company's investment property portfolio was adjusted downwards by HKD 0.723 billion [2] - The group recorded a loss of HKD 0.305 billion from joint ventures and associates, primarily from a joint venture in mainland China [2]
小马智行获纳入恒生综合指数 有望成为港股通标的
Zhi Tong Cai Jing· 2026-02-13 14:41
Group 1 - The Hang Seng Index Company announced the quarterly review results for the Hang Seng Index series as of December 31, 2025, with Pony.ai (02026) being included in the Hang Seng Composite Index [1] - The changes will be implemented after the market closes on March 6, 2026, and will take effect on March 9, 2026, leading to adjustments in the eligible stocks for the Hong Kong Stock Connect [1] - According to a report by CICC, Pony.ai is likely to be included in the Hong Kong Stock Connect due to meeting various criteria, including market capitalization, liquidity, and listing duration [1] Group 2 - On February 6, Pony.ai, known as the "first global Robotaxi stock," announced a strategic partnership with Moore Threads (688795.SH), a leading domestic full-function GPU company [1] - The collaboration will focus on the implementation and large-scale application of L4 autonomous driving technology, emphasizing deep cooperation on Pony.ai's core technologies, including the world model and virtual driver system training and optimization [1] - The partnership aims to leverage safe and reliable AI computing power to enhance the iteration of autonomous driving technology and its commercial deployment [1]
名创优品2月13日斥资198.67万港元回购5.26万股
Zhi Tong Cai Jing· 2026-02-13 14:41
名创优品(09896)发布公告,该公司于2026年2月13日斥资198.67万港元回购5.26万股股份,每股回购价 格为37.36-38港元。 ...
永太科技终止筹划发行股份购买资产事项 2月24日起复牌
Zhi Tong Cai Jing· 2026-02-13 14:41
Core Viewpoint - The company has decided to terminate the planned acquisition of a 25% stake in Shaowu Yongtai High-tech Materials Co., Ltd. from Contemporary Amperex Technology Co., Ltd. (CATL) and will resume trading of its shares on February 24, 2026 [1] Group 1 - The company initially intended to acquire the stake through a share issuance and raise matching funds [1] - The decision to terminate the transaction was made after careful consideration [1] - The company's stock will resume trading following the announcement of the termination [1]
春秋电子控股股东拟减持不超2%股份
Zhi Tong Cai Jing· 2026-02-13 14:41
春秋电子(603890)(603890.SH)发布公告,公司控股股东薛革文计划在公告之日起15个交易日后的3个 月内(即2026年3月17日至2026年6月16日)通过大宗交易方式减持公司股份不超过893.62万股(即不超过公 司总股本的2%)。 ...
军信股份港股IPO招股书失效
Zhi Tong Cai Jing· 2026-02-13 14:36
Group 1 - The core viewpoint of the article is that Junxin Environmental Protection Co., Ltd. (301109.SZ) submitted its Hong Kong IPO application, which will expire six months after submission, with CICC and CITIC Securities as joint sponsors [1] - Junxin Environmental Protection is a leading company in the industry, providing comprehensive waste treatment and resource utilization solutions, including investment, management, and operation of green environmental energy projects [2] - The company's main operational site, Changsha Environmental Industry Park, is one of the largest comprehensive environmental parks in China, covering multiple projects related to waste incineration power generation and comprehensive waste treatment [2]
劲方医药-B获纳入恒生指数系列及MSCI指数成份股
Zhi Tong Cai Jing· 2026-02-13 14:36
Group 1 - The company has been included in multiple indices, such as the Hang Seng Composite Index (HSCI), Hang Seng Hong Kong Stock Connect Index, and Hang Seng Innovative Drug Index, effective March 9, 2026 [1] - The inclusion in the MSCI Global Small Cap Index will take effect after the market closes on February 27, 2026, reflecting the company's growing recognition in the market [1] - The Hang Seng Composite Index covers the top 95% of companies listed on the Hong Kong Stock Exchange, making it a significant benchmark for index funds and performance evaluation [1] Group 2 - The company will also be included in various other Hang Seng indices, such as the Hang Seng Composite Small Cap Index and the Hang Seng Healthcare Index, indicating broad market acceptance [2] - The board believes that inclusion in these important indices demonstrates investor recognition of the company's value and growth potential, which is expected to enhance stock liquidity and diversify the shareholder base [2] - The company aims to strengthen its leading position in the RAS sector and enhance its international competitiveness in innovative drug fields, driving value creation through its R&D advantages [2]